# Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia

> **NCT01638585** · PHASE3 · TERMINATED · sponsor: **GWT-TUD GmbH** · enrollment: 34 (actual)

## Conditions studied

- Diabetic Foot
- Critical Limb Ischemia

## Interventions

- **DRUG:** urokinase

## Key facts

- **NCT ID:** NCT01638585
- **Lead sponsor:** GWT-TUD GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** recruition number was not reached
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638585, "Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01638585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*